CF Symposium 2016 08:00
Registration and continental breakfast
09:00
Welcome Word, Diane St-Jacques, CEO of Fibrose Kystique Québec & John Hanrahan, Director of CFTRc, McGill University
Session Chair: Gergely Lukacs, McGill University 09:10
Luis Galietta, University of Genoa, Italia Identification of novel F508del-CFTR modulators
09:50
Juan Ianowski, University of Saskatchewan, Sasktatoon, Canada The airway of CFTR knockout swine fail to respond to inhaled Pseudomonas aeruginosa.
10:30
Break, Scientific Posters and Press conference for the 35th anniversary of Fibrose Kystique Quebec
11:15
Lyne Gagnon, ProMetic, Montreal, Canada PBI-4050: A novel first-in-class antifibrotic agent displaying antidiabetic properties
11:25
Damien Adam, Université de Montréal, CRCHUM, Montreal, Canada Les canaux potassiques comme cibles thérapeutiques dans la réparation et la régénération de l’épithélium des voies aériennes fibrose kystique
11:45
Lane Clarke, University of Missouri, Columbia, USA Intestinal organoids to identify epithelial-autonomous effects of CF on goblet cell and stem cell function.
12:25
Lunch and Scientific Posters
13:30
Testimony of a CF patient: Audray Metcalfe
Session Chair: Dao Nguyen, McGill University 13:50
Guido Veit, McGill University, Montreal, Canada Ribosomal stalk protein silencing partially corrects the ΔF508-CFTR functional expression defect
14:10
Mitch Drumm, Case Western Reserve University, Cleveland, USA From gene to gene therapy, a CF concept revisited
14:50
Christine Bear, Hospital for Sick Children, Toronto, Canada Development of a CF clinical trial in a dish
15:30
Break and Scientific Posters
16:00
Don Sheppard, McGill University, Montreal, Canada Modelling what goes on in the airways: Aspergillus fumigatus infection in CF
16:45
Closing Word, John Hanrahan ; Awards and Cocktail offered by Traffick Therapeutics.
